Biocryst Pharmaceuticals buy TD Cowen
Start price
15.10.25
/
50%
€5.62
Target price
15.10.26
€25.82
Performance (%)
53.90%
Price
20.03.26
€8.65
Summary
This prediction is currently active. The BUY prediction by TD_Cowen for Biocryst Pharmaceuticals has seen massive gains of 53.90%. This prediction currently runs until 15.10.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 19.437% | 19.437% |
| iShares Core DAX® | -4,93 % | -11,98 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % |
| iShares S&P 500 | -2,54 % | -3,54 % |
Comments by TD_Cowen for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat